Welcome to LookChem.com Sign In|Join Free

CAS

  • or

191478-99-6

Post Buying Request

191478-99-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

191478-99-6 Usage

General Description

Benzoic acid, 4-amino-2,6-difluoro-, methyl ester (9CI) is a chemical compound with the molecular formula C8H7F2NO2. It is a methyl ester derivative of 4-amino-2,6-difluorobenzoic acid, which is a derivative of benzoic acid. Benzoic acid, 4-amino-2,6-difluoro-, methyl ester (9CI) may have various industrial and pharmaceutical applications, including as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is important to handle this chemical with care, as it may pose health and environmental hazards if not properly managed.

Check Digit Verification of cas no

The CAS Registry Mumber 191478-99-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,4,7 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 191478-99:
(8*1)+(7*9)+(6*1)+(5*4)+(4*7)+(3*8)+(2*9)+(1*9)=176
176 % 10 = 6
So 191478-99-6 is a valid CAS Registry Number.

191478-99-6Downstream Products

191478-99-6Relevant articles and documents

Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders

-

Paragraph 0677-0680, (2016/05/02)

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF

-

Paragraph 0192, (2015/02/25)

Provided are sulfonamide derivatives of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent α4 integrin-inhibitory action.

Methods of treatment with compounds having RARα receptor specific or selective activity

-

, (2008/06/13)

Retinoid compounds which act specifically or selectively on RARα receptor subtypes in preference over RARβ and RARγ receptor subtypes, posses desirable pharmaceutical properties associated with retinoids, and are particularly suitable for treatment of tumors, such as acute monocytic leukemia, cervical carcinoma, myeloma, ovarian carcinomas and head and neck carcinomas, without having one or more undesirable side effects of retinoids, such as inducement of weight loss, mucocutaneous toxicity, skin irritation and teratogenecity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 191478-99-6